This proposed Physician Scientist Award will enable me to pursue further training and research directed toward understanding the contribution of pubertal changes on the expression of affective illness, and the potential use of biological markers in juvenile depression. The training will provide the background to develop research strategies using pharmacologic probes to assess sleep and hormone regulation related particularly to the cholinergic system in juvenile populations. The study of adolescent depressives should help clarify what sleep and neuroendocrine abnormalities are state and trait correlates of affective illness in this age group. The proposed training and research is divisible into Phase I and Phase II: During the first two years of the funding period, Phase I, I will be immersed in a basic science learning experience consisting of didactic instruction in neurochemistry, statistical training, and sleep physiology, along with supervised laboratory work. The focus of Phase I will be to attain a thorough understanding of radioimmunoassay (RIA) methods for drug and hormone measurement, experience in the application of pharmacologic probes and stress paradigms in animals, and an understanding of responsiveness of cholinergically regulated hormone systems across developmental periods in animals. Phase II, or the second three years of proposed work, will involve clinical studies using the probes studied preclinically in Phase I in populations of depressed and recovered adolescents, non- depressed adolescents with other psychiatric illnesses, siblings of depressed adolescents, and normal volunteer adolescents. The proposed research, in addition to facilitating my career development, should shed light on what neuroendocrine abnormalities are central to affective illness at all ages, versus those that are epiphenomena of aging, exposure to stressors or repeated episodes of illness; and whether changes in cholinergic responsiveness with age underlie these abnormalities. This training will enable me to independently develop other potential pharmacologic probes for application in future studies of juvenile psychiatric disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Physician Scientist Award (K11)
Project #
5K11MH000722-03
Application #
3087982
Study Section
Research Scientist Development Review Committee (MHK)
Project Start
1987-09-30
Project End
1992-08-31
Budget Start
1989-09-01
Budget End
1990-08-31
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Los Angeles County Harbor-UCLA Medical Center
Department
Type
DUNS #
City
Torrance
State
CA
Country
United States
Zip Code
90509
McCracken, James T; Hanna, Gregory L (2005) Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment. J Child Adolesc Psychopharmacol 15:581-7
McCracken, J T; Poland, R E; Lutchmansingh, P et al. (1997) Sleep electroencephalographic abnormalities in adolescent depressives: effects of scopolamine. Biol Psychiatry 42:577-84
Poland, R E; Lutchmansingh, P; McCracken, J T et al. (1997) Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA. Psychopharmacology (Berl) 131:411-9
Rao, U; McCracken, J T; Lutchmansingh, P et al. (1997) Electroencephalographic sleep and urinary free cortisol in adolescent depression: a preliminary report of changes from episode to recovery. Biol Psychiatry 41:369-73
Rubin, R T; Phillips, J J; McCracken, J T et al. (1996) Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function. Biol Psychiatry 40:89-97
Poland, R E; Lutchmansingh, P; Au, D et al. (1996) Exposure to threshold doses of nicotine in utero: III. Augmentation of the prolactin and ACTH response to 8-OH DPAT by desipramine treatment is compromised in adult male offspring. Neurotoxicology 17:351-8
Granger, D A; Weisz, J R; McCracken, J T et al. (1996) Reciprocal influences among adrenocortical activation, psychosocial processes, and the behavioral adjustment of clinic-referred children. Child Dev 67:3250-62
Rubin, R T; Phillips, J J; Sadow, T F et al. (1995) Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 52:213-8
Poland, R E; Lutchmansingh, P; McGeoy, S et al. (1995) Prenatal stress prevents the desensitization of the corticosterone response to TFMPP by desmethylimipramine, but not by phenelzine, in adult male offspring. Life Sci 57:2163-70
Poland, R E; Lutchmansingh, P; Au, D et al. (1994) Exposure to threshold doses of nicotine in utero: I. Neuroendocrine response to restraint stress in adult male offspring. Life Sci 55:1567-75

Showing the most recent 10 out of 19 publications